Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents

Accounts of Chemical Research

Volumn 42, Issue 7, 2009, Pages 938-947

  Datta, Ankona ^a   Raymond, Kenneth N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; HYDROXYPYRIDINES; LIGAND; PROTON; PYRIDINE DERIVATIVE; WATER;

ARTICLE; CHEMISTRY; CONFORMATION; IMAGE ENHANCEMENT; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

CONTRAST MEDIA; CRYSTALLOGRAPHY, X-RAY; GADOLINIUM; IMAGE ENHANCEMENT; LIGANDS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MOLECULAR CONFORMATION; PROTONS; PYRIDINES; THERMODYNAMICS; WATER;

EID: 67651122843     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar800250h     Document Type: Article

References (50)

1. Lauffer, R. B. Paramagnetic metal complexes as water proton relaxation agents for NMR imagingsTheory and design. Chem. Rev. 1987, 87 (5), 901-927.
2. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging; Merbach, A. E., Tó th, E., Eds.; Wiley: Chichester, U.K., 2001.
3. Toth, E.; Helm, L.; Merbach, A. E. Relaxivity of MRI contrast agents. Top. Curr. Chem. 2002, 221, 61-101.
4. Caravan, P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 2006, 35 (6), 512-523. (Pubitemid 43815285)
5. Caravan, P.; Ellison, J.; McMurry, T.; Lauffer, R. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 1999, 99 (9), 2293-2352. (Pubitemid 30498114)
6. Kumar, K.; Tweedle, M. F. Macrocyclic polyaminocarboxylate complexes of lanthanides as magnetic resonance imaging contrast agents. Pure Appl. Chem. 1993, 65 (3), 515-520. (Pubitemid 127415068)
7. Bloembergen, N. Spin relaxation processes In a 2-proton system. Phys. Rev. 1956, 104 (6), 1542-1547.
8. Bloembergen, N.; Morgan, L. O. Proton relaxation times in paramagnetic solutions effects of electron spin relaxation. J. Chem. Phys. 1961, 34 (3), 842-850.
9. Solomon, I. Relaxation processes in a system of 2 spins. Phys. Rev. 1955, 99 (2), 559-565.
10. Solomon, I.; Bloembergen, N. Nuclear magnetic interactions in the HF molecule. J. Chem. Phys. 1956, 25 (2), 261-266.
11. Aime, S.; Crich, S. G.; Gianolio, E.; Giovenzana, G. B.; Tei, L.; Terreno, E. High sensitivity lanthanide(III) based probes for MR-medical imaging. Coord. Chem. Rev. 2006, 250 (11-12), 1562-1579.
12. Chan, K. W. Y.; Wong, W. T. Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord. Chem. Rev. 2007, 251, 2428-2451.
13. Frullano, L.; Meade, T. J. Multimodal MRI contrast agents. J. Biol. Inorg. Chem. 2007, 12 (7), 939-949. (Pubitemid 47353540)
14. Hermann, P.; Kotek, J.; Kubicek, V.; Lukes, I. Gadolinium(III) complexes as MRI contrast agents: Ligand design and properties of the complexes. Dalton Trans. 2008, (23), 3027-3047.
15. Major, J. L.; Parigi, G.; Luchinat, C.; Meade, T. J. The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (35), 13881-13886. (Pubitemid 350003305)
16. Moats, R. A.; Fraser, S. E.; Meade, T. J. A "smart" magnetic resonance imaging agent that reports on specific enzymatic activity. Angew. Chem., Int. Ed. 1997, 36 (7), 726-728. (Pubitemid 27299278)
17. Que, E. L.; Chang, C. J. A smart magnetic resonance contrast agent for selective copper sensing. J. Am. Chem. Soc. 2006, 128, 15942-15943. (Pubitemid 44936540)
18. Sherry, A. D.; Woods, M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu. Rev. Biomed. Eng. 2008, 10, 391-411.
19. Zhang, X. A.; Lovejoy, K. S.; Jasanoff, A.; Lippard, S. J. Water-soluble porphyrins imaging platform for MM zinc sensing. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (26), 10780-10785.
20. Helm, L.; Merbach, A. E. Water exchange on metal ions: Experiments and simulations. Coord. Chem. Rev. 1999, 187, 151-181.
21. Pidcock, E.; Moore, G. R. Structural characteristics of protein binding sites for calcium and lanthanide ions. J. Biol. Inorg. Chem. 2001, 6 (5-6), 479-489. (Pubitemid 32822109)
22. Yang, Z. R.; Batra, R.; Floyd, D. L.; Hung, H. C.; Chang, G. G.; Tong, L. Potent and competitive inhibition of malic enzymes by lanthanide ions. Biochem. Biophys. Res. Commun. 2000, 274 (2), 440-444. (Pubitemid 30614337)
23. Burling, F. T.; Weis, W. I.; Flaherty, K. M.; Brunger, A. T. Direct observation of protein solvation and discrete disorder with experimental crystallographic phases. Science 1996, 271 (5245), 72-77.
24. Ng, K. K. S.; Kolatkar, A. R.; Park-Snyder, S.; Feinberg, H.; Clark, D. A.; Drickamer, K.; Weis, W. I. Orientation of bound ligands in mannose-binding proteinssImplications for multivalent ligand recognition. J. Biol. Chem. 2002, 277 (18), 16088-16095. (Pubitemid 34967894)
25. Allen, M.; Bulte, J. W. M.; Liepold, L.; Basu, G.; Zywicke, H. A.; Frank, J. A.; Young, M.; Douglas, T. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn. Reson. Med. 2005, 54 (4), 807-812. (Pubitemid 41457051)
26. Aime, S.; Botta, M.; Terreno, E. Gd(III)-Based Contrast Agents for MRI; Elsevier: Amsterdam, The Netherlands, 2005; Vol.57, pp 173-237.
27. Xu, J.; Franklin, S. J.; Whisenhunt, D. W.; Raymond, K. N. Gadolinium complex of tris[(3-hydroxy-1-methyl-2-oxo-1,2-didehydropyridine-4- carboxamido)ethyl]aminesA new class of gadolinium magnetic-resonance relaxation agents. J. Am. Chem. Soc. 1995, 117 (27), 7245-7246.
28. total = 1 μM, [L]total = 10 μM (pH 7.4, 25 °C, 0.1 M KCL)
29. Werner, E. J.; Datta, A.; Jocher, C. J.; Raymond, K. N. Recent developments in the pursuit of high-relaxivity MRI contrast agents. Angew. Chem., Int. Ed. 2008, 47 (45), 8568-8580.
30. Werner, E. J.; Avedano, S.; Botta, M.; Hay, B. P.; Moore, E. G.; Aime, S.; Raymond, K. N. Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity. J. Am. Chem. Soc. 2007, 129 (7), 1870-1871. (Pubitemid 46318242)
31. Powell, D. H.; Ni Dhubhghaill, O. M.; Pubanz, D.; Helm, L.; Lebedev, Y. S.; Schlaepfer, W.; Merbach, A. E. Structural and dynamic parameters obtained from 17O NMR, EPR, and NMRD studies of monomeric and dimeric Gd3+ complexes of interest in magnetic resonance imaging: An integrated and theoretically self-consistent approach. J. Am. Chem. Soc. 1996, 118 (39), 9333-9346. (Pubitemid 26355128)
32. Xu, J. D.; Radkov, E.; Ziegler, M.; Raymond, K. N. Plutonium(IV) sequestration: Structural and thermodynamic evaluation of the extraordinarily stable cerium(IV) hydroxypyridinonate complexes. Inorg. Chem. 2000, 39 (18), 4156-4164.
33. Xu, J.; Churchill, D. G.; Botta, M.; Raymond, K. N. Gadolinium(III) 1,2- hydroxypyridonate-based complexes: Toward MRI contrast agents of high relaxivity. Inorg. Chem. 2004, 43 (18), 5492-5494.
34. Cohen, S. M.; Xu, J. D.; Radkov, E.; Raymond, K. N.; Botta, M.; Barge, A.; Aime, S. Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents. Inorg. Chem. 2000, 39 (25), 5747-5756. (Pubitemid 32063874)
35. Thompson, M. K.; Botta, M.; Nicolle, G.; Helm, L.; Aime, S.; Merbach, A. E.; Raymond, K. N. A highly stable gadolinium complex with a fast, associative mechanism of water exchange. J. Am. Chem. Soc. 2003, 125 (47), 14274-14275. (Pubitemid 37452355)
36. Aime, S.; Botta, M.; Crich, S. G.; Giovenzana, G.; Pagliarin, R.; Sisti, M.; Terreno, E. NMR relaxometric studies of Gd(III) complexes with heptadentate macrocyclic ligands. Magn. Reson. Chem. 1998, 36, S200-S208. (Pubitemid 128093197)
37. Doble, D. M. J.; Botta, M.; Wang, J.; Aime, S.; Barge, A.; Raymond, K. N. Optimization of the relaxivity of MRI contrast agents: Effect of poly(ethylene glycol) chains on the water-exchange rates of GdIII complexes. J. Am. Chem. Soc. 2001, 123 (43), 10758-10759. (Pubitemid 33015729)
38. Pierre, V. C.; Botta, M.; Raymond, K. N. Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength. J. Am. Chem. Soc. 2005, 127 (2), 504-505. (Pubitemid 40174359)
39. Datta, A.; Hooker, J. M.; Botta, M.; Francis, M. B.; Aime, S.; Raymond, K. N. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: Nanosized MRI contrast agents. J. Am. Chem. Soc. 2008, 130 (8), 2546-2552. (Pubitemid 351304769)
40. Hajela, S.; Botta, M.; Giraudo, S.; Xu, J. D.; Raymond, K. N.; Aime, S. A trishydroxymethyl- substituted derivative of Gd-TREN-Me-3,2-HOPO: An MRI relaxation agent with improved efficiency. J. Am. Chem. Soc. 2000, 122 (45), 11228-11229. (Pubitemid 30844190)
41. Hajela, S. P.; Johnson, A. R.; Xu, J. D.; Sunderland, C. J.; Cohen, S. M.; Caulder, D. L.; Raymond, K. N. Synthesis of homochiral tris(2-alkyl-2- aminoethyl)amiderivatives from chiral R-amino aldehydes and their application in the synthesis of water soluble chelators. Inorg. Chem. 2001, 40 (13), 3208-3216.
42. Hay, B. P.; Werner, E. J.; Raymond, K. N. Estimating the number of bound waters in Gd(III) complexes revisited. Improved methods for the prediction of q-values. Bioconjugate Chem. 2004, 15 (6), 1496-1502.
43. Barrett, T.; Kobayashi, H.; Brechbiel, M.; Choyke, P. L. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur. J. Radiol. 2006, 60 (3), 353-366. (Pubitemid 44779078)
44. Toth, E.; Helm, L.; Kellar, K. E.; Merbach, A. E. Gd(DTPA-bisamide)alkyl copolymers: A hint for the formation of MRI contrast agents with very high relaxivity. Chem.-Eur. J. 1999, 5 (4), 1202-1211.
45. Thompson, M. K.; Doble, D. M. J.; Tso, L. S.; Barra, S.; Botta, M.; Aime, S.; Raymond, K. N. Hetero-tripodal hydroxypyridonate gadolinium complexes: Syntheses, relaxometric properties, water exchange dynamics, and human serum albumin binding. Inorg. Chem. 2004, 43 (26), 8577-8586. (Pubitemid 40024170)
46. Anderson, E. A.; Isaacman, S.; Peabody, D. S.; Wang, E. Y.; Canary, J. W.; Kirshenbaum, K. Viral nanoparticles donning a paramagnetic coat: Conjugation of MRI contrast agents to the MS2 capsid. Nano Lett. 2006, 6 (6), 1160-1164. (Pubitemid 44013476)
47. Prasuhn, D. E.; Yeh, R. M.; Obenaus, A.; Manchester, M.; Finn, M. G. Viral MRI contrast agents: Coordination of Gd by native virions and attachment of Gd complexes by azide-alkyne cycloaddition. Chem. Commun. 2007, (12), 1269-1271. (Pubitemid 46412124)
48. Hooker, J. M.; Datta, A.; Botta, M.; Raymond, K. N.; Francis, M. B. Magnetic resonance contrast agents from viral capsid shells: A comparison of exterior and interior cargo strategies. Nano Lett. 2007, 7, 2207-2210. (Pubitemid 47310107)
49. Valegard, K.; Liljas, L.; Fridborg, K.; Unge, T. The 3-dimensional structure of the bacterial-virus MS2. Nature 1990, 345 (6270), 36-41.
50. Aime, S.; Botta, M.; Crich, S. G.; Giovenzana, G.; Pagliarin, R.; Sisti, M.; Terreno, E. NMR relaxometric studies of Gd(III) complexes with heptadentate macrocyclic ligands. Magn. Reson. Chem. 1998, 36, S200-S208. (Pubitemid 128093197)